P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
PTGX | N/A | N/A | N/A | -40.93% |
PTGX Peer | 29.9 | 3.2 | N/A | -88.46% |
Pharmaceuticals: Major Industry | 25.9 | 18.1 | 0.1 | +40.47% |
Health Technology Sector | 39.2 | 29.4 | 0.5 | +76.25% |
S&P 500 Market | 30.1 | 22.4 | 2.1 | +73.70% |
Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
---|---|---|---|---|
Mean Estimate | -$0.64 | -$0.72 | -$0.70 | -$0.64 |
Previous Mean | -$0.72 | -$0.72 | -$0.70 | -$0.64 |
Standard Deviation | 0.17 | 0.08 | 0.03 | 0.07 |
Low Estimate | -$0.82 | -$0.84 | -$0.74 | -$0.70 |
High Estimate | -$0.36 | -$0.67 | -$0.67 | -$0.55 |